scholarly journals Effect of a Tailored Dietary Intervention with High or Standard Protein Intake on B-Vitamin and One Carbon Metabolism Status in Healthy Older Males: A 10 Week Randomised Controlled Trial

Proceedings ◽  
2019 ◽  
Vol 8 (1) ◽  
pp. 19
Author(s):  
Nicola Gillies ◽  
Amber M. Milan ◽  
Pankaja Sharma ◽  
Brenan Durainayagam ◽  
Sarah M. Mitchell ◽  
...  

Background: Maintaining optimal status of folate and metabolically [...]

Proceedings ◽  
2019 ◽  
Vol 8 (1) ◽  
pp. 36
Author(s):  
Nicola Gillies ◽  
Amber M. Milan ◽  
Pankaja Sharma ◽  
Brenan Durainayagam ◽  
Sarah M. Mitchell ◽  
...  

Background: Maintaining optimal status of folate and metabolically related vitamins (riboflavinand vitamins B6 and B12) is increasingly important for older adults [...]


2013 ◽  
Vol 13 (1) ◽  
Author(s):  
Adrienne O’Neil ◽  
Michael Berk ◽  
Catherine Itsiopoulos ◽  
David Castle ◽  
Rachelle Opie ◽  
...  

2020 ◽  
pp. 1-13
Author(s):  
Samantha L Dawson ◽  
Mohammadreza Mohebbi ◽  
Jeffrey M Craig ◽  
Phillip Dawson ◽  
Gerard Clarke ◽  
...  

Abstract Objective: To evaluate the hypothesis that a perinatal educational dietary intervention focused on ‘eating for the gut microbiota’ improves diet quality of pregnant women pre- and postnatally. Design: The Healthy Parents, Healthy Kids study is a prospectively registered randomised controlled trial designed to evaluate the efficacy of a dietary intervention in altering the maternal and infant gut microbiota and improving perinatal diet quality. Eligible pregnant women were randomised to receive dietary advice from their healthcare provider or to additionally receive a three session dietary intervention. Dietary data were collected at gestation weeks 26, 31, 36 and postnatal week 4. Outcome measures were diet quality, dietary variety, prebiotic and probiotic food intakes, energy, fibre, saturated fat and discretionary food intakes. Between-group differential changes from baseline before and after birth in these dietary measures were assessed using generalised estimating equations. Setting: Melbourne, Australia. Participants: Healthy pregnant women from gestation week 26. Results: Forty-five women were randomised (twenty-two control, twenty-three intervention). Compared with the control group, the intervention group improved diet quality prior to birth (5·66 (95 % CI 1·65, 9·67), Cohen’s d: 0·82 (se 0·33)). The intervention improved dietary variety (1·05 (95 % CI 0·17, 1·94), d: 0·66 (se 0·32)) and increased intakes of prebiotic (0·8 (95 % CI 0·27, 1·33), d: 0·91 (se 0·33)) and probiotic foods (1·05 (95 % CI 0·57, 1·53), d: 1·3(se 0·35)) over the whole study period compared with the control group. Conclusion: A dietary intervention focused on ‘eating for the gut microbiota’ can improve aspects of perinatal diet quality during and after pregnancy.


BMJ Open ◽  
2019 ◽  
Vol 9 (7) ◽  
pp. e027893 ◽  
Author(s):  
Daren K Heyland ◽  
Andrew Day ◽  
G John Clarke ◽  
Catherine (Terri) Hough ◽  
D Clark Files ◽  
...  

IntroductionSurvivors of critical illness often experience significant morbidities, including muscle weakness and impairments in physical functioning. This muscle weakness is associated with longer duration mechanical ventilation, greater hospital costs and increased postdischarge impairments in physical function, quality of life and survival. Compared with standard of care, the benefits of greater protein intake combined with structured exercise started early after the onset of critical illness remain uncertain. However, the combination of protein supplementation and exercise in other populations has demonstrated positive effects on strength and function. In the present study, we will evaluate the effects of a combination of early implementation of intravenous amino acid supplementation and in-bed cycle ergometry exercise versus a ‘usual care’ control group in patients with acute respiratory failure requiring mechanical ventilation in an intensive care unit (ICU).Methods and analysisIn this multicentre, assessor-blinded, randomised controlled trial, we will randomise 142 patients in a 1:1 ratio to usual care (which commonly consists of minimal exercise and under-achievement of guideline-recommended caloric and protein intake goals) versus a combined intravenous amino acid supplementation and in-bed cycle ergometery exercise intervention. We hypothesise that this novel combined intervention will (1) improve physical functioning at hospital discharge; (2) reduce muscle wasting with improved amino acid metabolism and protein synthesis in-hospital and (3) improve patient-reported outcomes and healthcare resource utilisation at 6 months after enrolment. Key cointerventions will be standardised. In-hospital outcome assessments will be conducted at baseline, ICU discharge and hospital discharge. An intent-to-treat analysis will be used to analyse all data with additional per-protocol analyses.Ethics and disseminationThe trial received ethics approval at each institution and enrolment has begun. These results will inform both clinical practice and future research in the area. We plan to disseminate trial results in peer-reviewed journals, at national and international conferences, and via nutritional and rehabilitation-focused electronic education and knowledge translation platforms.Trial registration numberNCT03021902; Pre-results.


2020 ◽  
Vol 79 (OCE2) ◽  
Author(s):  
Vegard Lysne ◽  
Anthea van Parys ◽  
Thomas Olsen ◽  
Ingvild Marienborg ◽  
Johnny Laupsa-Borge ◽  
...  

AbstractIntroduction:Peroxisome Proliferator-Activated Receptor α (PPARα) is a known regulator of lipid and energy metabolism. In animal experiments of PPARα activation, we have reported on altered plasma concentration of metabolites related to one-carbon metabolism and B-vitamin status. Several of these metabolites, e.g. homocysteine and dimethylglycine, have been associated with increased cardiovascular disease risk. Diet can influence one-carbon metabolism, and this may partly be mediated through altered PPARα activity as dietary fatty acids can activate PPARα. As diet is a modifiable life style factor, the aim of this investigation is to explore potential associations between dietary composition and plasma concentration of one-carbon metabolites and markers of B-vitamin status.Materials and methods:The study population consisted of 1977 patients with stable angina (geometric mean age 61 years, 80% male) from the Western Norway B-vitamin Intervention Trial (WENBIT), who completed a self-administered food frequency questionnaire at baseline. Data on outcome variables were obtained from the baseline blood samples (35% fasting). Outcome variables of interest were metabolites related to one-carbon metabolism and B-vitamin status. Cross-sectional associations between protein, carbohydrate and fat intake with the outcome metabolites were analysed with linear regression, adjusted for age, sex, fasting status, BMI and reported energy intake. Estimates are given as % change in the outcome variable per isoenergetic increment of 1 energy % (E%) in the exposure nutrient.Results:The average distribution [95% prediction interval] of energy intake (E%) in the population was 48.5 (37.1, 63.4) from carbohydrate, 31.4 (21.9, 44.9) from fat and 16.5 (12.2, 22.3) from protein.The strongest associations were seen for increasing protein intake, while the associations with fat and carbohydrate intake were weaker. The most pronounced associations (% change [95% confidence interval]) with increasing protein intake were higher cobalamin (2.9 [2.1, 3.7]), PLP (2.7 [1.7, 3.7]) and riboflavin (2.3 [1.0, 3.6]), and lower tHcy (-1.4 [-1.9, -0.9]) and MMA (-1.3 [-1.9, -0.7]).Discussion:The current observations indicate that dietary macronutrient composition may influence plasma concentration of one-carbon metabolites and markers of B-vitamin status. The strongest associations are observed with increasing protein intake, but elucidating the importance of the nutrient substituted remains. Whether the observed associations are due to macronutrients per se, or reflect differences in food choices/nutrient intakes, or effects on physiological factors, i.e. inflammation or PPARα activation, is not known.


Sign in / Sign up

Export Citation Format

Share Document